For Alzheimer's Agitation, Promising News from Rexulti (Brexpiprazole)
Descrição
Rexulti (brexpiprazole) shares positive trial results for treating agitation in Alzheimer's. Following this a bumpy road for another Alzheimer's drug candidate that could supplant the need for antipsychotics to treat behavioral Alzheimer's symptoms, this could be the first such drug approved — if its safety and efficacy data stay on track.
FDA OKs First Drug for Agitation in Alzheimer's Dementia
Prazosin Looks Promising for Agitation in Dementia [AlzWeek.com]
Dementia Treatment - Hallucinations & Agitation Treatment
Frontiers Agitation and Dementia: Prevention and Treatment
Antipsychotic Shows Benefit for Alzheimer's Agitation
Brexpiprazole (Rexulti): Uses, Side Effects, Warnings & More - GoodRx
Rexulti backed for Alzheimer's agitation by FDA adcomm
FDA approves first drug meant to ease Alzheimer's-linked agitation
Investigation Questions Drug's Approval for Agitation in AD
FDA nod for Rexulti sNDA in treatment of Alzheimer's agitation
Lundbeck, Otsuka drug cut agitation in Alzheimer's patients
Light Therapy for Alzheimer's Shows Promise for Sleep and Behavior
Brexpiprazole (Rexulti) Approved for Alzheimer's Agitation
Targets, trials and tribulations in Alzheimer therapeutics
de
por adulto (o preço varia de acordo com o tamanho do grupo)
